JP Stock MarketDetailed Quotes

1802 Obayashi

Watchlist
  • 2093.0
  • -7.5-0.36%
20min DelayMarket Closed Dec 30 15:30 JST
1.51TMarket Cap19.99P/E (Static)

Obayashi Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Obayashi Q2 2025 Earnings Date

Currency：JPYNov 11, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
616.34B
665.89B
+49.55B
Beat Est.
+3.78%
+12.12%
+8.04%
EPS
22.03
40.80
+18.77
Beat Est.
-31.77%
+26.36%
+85.20%
Analyst Rating
Strong Buy

Nov 28, 2024

Obayashi Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 663.404B--
Feb 10, 20252025/Q3-- / 653.710B--
Nov 11, 20242025/Q2665.890B / 616.343B--
Aug 6, 20242025/Q1574.706B / 535.432B--
May 13, 20242024/Q4623.613B / 602.399B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 663.404B--
Feb 10, 20252025/Q3-- / 653.710B--
Nov 11, 20242025/Q2665.890B / 616.343B--
Aug 6, 20242025/Q1574.706B / 535.432B--
May 13, 20242024/Q4623.613B / 602.399B--

Unlock Free Earnings Estimates

Obayashi Earnings Reports

  • Obayashi: Extraordinary Report

    Dec 24, 2024 20:55 ET

  • Obayashi: Confirmation letter

    Nov 11, 2024 19:35 ET

  • Obayashi: Half-Year Report - 121st Term (2024/04/01 - 2025/03/31)

    Nov 11, 2024 19:34 ET

  • Obayashi: Financial results briefing materials for the 2nd quarter (interim period) of the fiscal year ending 2025/3

    Nov 11, 2024 01:00 ET

    • Read more

    Top JP Stock Gainers
    Symbol Price % Chg
    Kyogoku unyu shoji
    9073
    1599 +58.32%
    BlueMeme
    4069
    1337 +28.93%
    Estore
    4304
    1904 +26.60%
    Visumo
    303A
    2036 +24.45%
    D. Western Therapeutics Institute
    4576
    201 +23.31%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Nov 28, 2024

    Strong Buy

    • Strong Buy

      62.50%

    • Buy

      37.50%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data